Piper Jaffray Reiterates “Overweight” Rating on Genzyme Corp (NASDAQ: GENZ) American Banking News The Company's product and service portfolio is focused on rare genetic disease disorders, renal diseases, orthopaedics, cancer, transplant and immune ... |
KAI Pharmaceuticals Announces Phase 1 Results of KAI-4169 for the Treatment of ... PipelineReview.com (press release) Secondary hyperparathyroidism develops early in chronic kidney disease (CKD) and worsens as renal function declines and progresses to end-stage renal ... and more » |
 UberGizmo (blog) | Redbox To Develop An Online Streaming Service To Compete With Netflix UberGizmo (blog) Word is going around that Redbox is currently exploring the possibility of expanding its movie renal service beyond kiosks and onto the Internet. ... and more » |
BMC Renal Dialysis Unit Receives High Marks in CMS Report iBerkshires.com The Renal Dialysis Unit at Berkshire Medical Center has been documented as providing remarkable patient care results in the past four years, according to a ... |
 CBC.ca | British PM David Cameron holds talks with President Barack Obama TimesNewsline.com The Libyan, who is ill with terminal prostate cancer, was released by Scottish Justice Minister Kenny MacAskill in August last year on compassionate grounds ... MacAskill 'happy to assist' US Megrahi questionsBBC News Will Megrahi's release impede London-WashingtonThe Voice of Russia Cameron meets senators regarding LockerbieecPulse InTheNews.co.uk -Discountvouchers.co.uk -First Post all 3,371 news articles » |
MediGene Earns €25M with Astellas' Purchase of Euro Rights to Marketed ... Genetic Engineering News MediGene has sold full European marketing and distribution rights to its prostate cancer drug Eligard® to Astellas Pharma Europe for €25 million (about ... MediGene sells full European rights for Eligard® to Astellas for EUR 25 ...PR-inside.com (press release) MEDIGENE NA : sells full European rights for Eligard® to Astellas for EUR 25 ...4-traders (press release) all 6 news articles » |
 The Hindu | Study: Troops have higher rates of some cancers ArmyTimes.com However, breast cancer and prostate cancer rates were significantly higher in both black and white troops than in civilians. Prostate cancer rates were also ... American Cancer Society Report Shows Cancer Rates DecliningMesothelioma Cancer News (press release) Cancer drug olaparib shows early promiseSeattle Times all 185 news articles » |
Key pathway in end-stage prostate cancer tumor progression blocked EurekAlert (press release) DALLAS – July 22, 2010 – Prostate cancer advances when tumors become resistant to hormone therapy, which is the standard treatment for patients, ... and more » |
The Launch and Uptake of Nine Emerging Therapies Will Drive the Prostate ... PR Newswire (press release) The Pharmacor 2010 findings from the topic entitled Prostate Cancer reveal that sales of emerging therapies, most notably Dendreon's Provenge, will account ... Prostate Cancer News: Jevtana approved by the FDAAll News 365 (blog) Sanofi-aventis says Jevtana injection available in USpharmabiz.com Sanofi-Aventis Reveals Availability Of Jevtana Injection In US - Quick FactsRTT News Pharmaceutical Business Review all 20 news articles » |
 Daily Mail | A long ring finger may mean you're a prostate cancer risk Daily Mail Men with a long ring finger could be three times more likely to develop prostate cancer, research shows. Doctors found that the risk increases ... Cleveland Clinic uses new prostate cancer screening testPlain Dealer Andrew Lloyd-Webber Urges for Prostate Cancer Check-UpTopNews United States USC Leads International Program Aimed At Identifying Prostate Cancer RiskNewswise (press release) BBC News -ConnectTriStates.com powered by KHQA -WKYC-TV all 17 news articles » |
